For US residents only.

My Living Proof

That treating newly diagnosed FLT3+ AML has changed—with RYDAPT

INDICATION for RYDAPT® (midostaurin) capsules

RYDAPT is an oral prescription medicine used in combination with certain chemotherapy medicines to treat adults with newly diagnosed acute myeloid leukemia (AML) who have a defect in a gene called FLT...

See More
IMPORTANT SAFETY INFORMATION for RYDAPT® (midostaurin) capsules
Allergic Reactions
  • Do not take RYDAPT if you are allergic to midostaurin or any of the ingredients in RYDAPT
  • If you develop signs of an allergic reaction, seek medical help immediately
  • Signs of an allergic reaction include trouble breathing, flushing, chest pain, throat tightness, and sw...
See More
LEARN MORE ABOUT

A Treatment for Patients With Newly Diagnosed FLT3+ Acute Myeloid Leukemia (AML)

Read more to see if prescription RYDAPT® (midostaurin) capsules may be right for you.

LEARN MORE
LEARN MORE ABOUT

Disease Information for FLT3+ AML

Information about AML and a mutation in a gene called FLT3.

LEARN MORE